Advertisement

Ads Placeholder
Loading...

ARIAD Pharmaceuticals, Inc.

ARIA•NASDAQ
Healthcare
Biotechnology
$23.99
$0.00(0.00%)
U.S. Market opens in 42h 43m

ARIAD Pharmaceuticals, Inc. (ARIA) Stock Overview

Explore ARIAD Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-19.81
EPS (TTM)N/A
ROE20.69%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

ARIA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ARIAD Pharmaceuticals, Inc. (ARIA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -19.81 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

NaN
NaN
NaN, NaN, NaN, NaN

Company Facts

IPO DateJan 2, 2001
CountryNaN

Frequently Asked Questions